Aims  The aim of this study was to determine the contemporary use of reperfusion therapy in the European Society of Cardiology (ESC) member and affiliated countries and adherence to ESC clinical practice guidelines in patients with ST-elevation myocardial infarction (STEMI). Methods and results  Prospective cohort (EURObservational Research Programme STEMI Registry) of hospitalized STEMI patients with symptom onset <24 h in 196 centres across 29 countries. A total of 11 462 patients were enrolled, for whom primary percutaneous coronary intervention (PCI) (total cohort frequency: 72.2%, country frequency range 0–100%), fibrinolysis (18.8%; 0–100%), and no reperfusion therapy (9.0%; 0–75%) were performed. Corresponding in-hospital mortality rates from any cause were 3.1%, 4.4%, and 14.1% and overall mortality was 4.4% (country range 2.5–5.9%). Achievement of quality indicators for reperfusion was reported for 92.7% (region range 84.8–97.5%) for the performance of reperfusion therapy of all patients with STEMI <12 h and 54.4% (region range 37.1–70.1%) for timely reperfusion. Conclusions  The use of reperfusion therapy for STEMI in the ESC member and affiliated countries was high. Primary PCI was the most frequently used treatment and associated total in-hospital mortality was below 5%. However, there was geographic variation in the use of primary PCI, which was associated with differences in in-hospital mortality.

Background: The worldwide incidence of congenital anomalies (CAs) is estimated at 3–7%, but actual numbers vary widely among countries. Birth defects are the most common causes of infantile mortality, accounting for ~25% of all neonatal deaths. Aims: To determine the prevalence of congenital anomalies in neonates in Fayoum Governorate; to classify malformations; and to clarify the association between congenital anomalies and possible risk factors. Methods: A cross-sectional study was conducted on 1000 infants in the neonatal intensive care unit and outpatient clinics of Fayoum University Hospital and Fayoum General Hospital during August 2017 to April 2018. Detailed history, clinical examination and relevant investigations were performed. Results: The prevalence of CAs was 7.4%. Major malformations accounted for 78.4% and minor malformations 21.6%. The most common CAs involved the cardiovascular system (32.4%), followed by musculoskeletal anomalies (18.9%), chromosomal anomalies (10.8%), anomalies of the central nervous system (9.5%), gastrointestinal tract (6.8%), genital system (5.4%), eyes, head and neck (5.4%), respiratory system (4.1%), multisystems (2 or more) (4.1%), and renal and urinary systems (2.7%). 82.4% of cases were from rural areas, 62.1% were male, 36.5% were female and 1.4% were ambiguous. 85.1% of neonates with malformations were full term. Conclusion: Cardiovascular, musculoskeletal and chromosomal anomalies were the most common CAs in our study. Positive consanguinity, poor attendance at antenatal clinics, rural residence and multiparty were the most common risk factors associated with CAs.

No abstract

Background:Patients with stable coronary artery disease may have subtle derangements in their cardiac function before evident changes in conventional echocardiographyderived ejection fraction (EF). These derangements manifest firstly in the longitudinal before circumferential LV function. The effect of PCI on longitudinal and circumferential systolic and diastolic function of the ventricle in patients with chronic stable angina has shown controversial results. In the current study, we tried to evaluate the impact of percutaneous coronary intervention (PCI) on myocardial systolic and diastolic function assessed by different non-invasive indices as EF, Myocardial Performance Index (MPI) and longitudinal myocardial function assessed by Tissue Doppler imaging (TDI) in patients with stable coronary artery disease.

No abstract

No abstract

Introduction: Diabetes mellitus is a chronic condition with devastating cardiovascular complications. Earlier studies have reported a gender-based difference in major adverse cardiac events (MACEs) after index PCI procedures. In the drug eluting stent era, more recent studies have failed to show any differences in post-PCI outcomes between both genders. However, this finding has never been verified in Egyptian patients with diabetes. The aim of the study: The aim of the study was to compare the impact of female gender on shortand long-term outcomes after elective PCI using drug-eluting stents (DES) in Egyptian diabetic patients.Patients and method: The study included 100 diabetic males and 100 diabetic females, all of whom had DES deployed during elective PCI and followed up for 12 months. The clinical endpoints were death, myocardial infarction (MI), target vessel revascularization (TVR), or target lesion revascularization (TLR) at any time during 12 month follow-up period. Results: Both diabetic females and males have a low and nearly equal incidence of adverse events following PCI using DES. Conclusion: When all patients had DES implanted and after adjustment of demographic and risk factor/co morbidity profiles, there were no significant differences in the short-or long-term PCI outcomes of diabetic females treated with DES when compared to diabetic males.